PVM Graduate Students Stand Out at Health and Disease Poster Session
Friday, March 27th, 2020 - When Purdue University hosted the seventh annual “Health and Disease: Science, Technology, Culture and Policy Research Poster Session” just before Spring Break, Purdue Veterinary Medicine graduate students showed-up in force. Held March 5 in the Purdue Memorial Union North Ballroom, the event offered cash prizes for the top three posters in each of six categories and PVM participants claimed three of the awards.
PVM-led Research on the Blood-Brain Barrier Featured on Cover of Scientific Journal
Friday, November 15th, 2019 - The most recently published research by the Comparative Blood-Brain Barrier Laboratory in Purdue Veterinary Medicine’s Department of Comparative Pathobiology, was featured on the cover of Oncotarget, a peer-reviewed bio-medical journal. Dr. Gozde Uzunalli, postdoctoral research associate, was the first author of the article, which highlighted how the blood-brain barrier transitions into the blood-tumor barrier when it is disturbed by cancer cells. The research was led by Dr. Tiffany Lyle, assistant professor of veterinary anatomic pathology.
BMS Faculty Member Finds that Urine Analysis Could Speed Diagnosis of Traumatic Brain Injury
Friday, September 13th, 2019 - A team of scientists led by Dr. Riyi Shi, Purdue Veterinary Medicine professor of basic medical sciences, has conducted research indicating that soldiers and athletes could have improved outcomes from traumatic brain injury through faster diagnosis using urine analysis.
Research Led by PVM’s Dr. Riyi Shi Utilizes World War II Antidote in Battle Against Parkinson’s Disease
Friday, December 7th, 2018 - A Purdue Veterinary Medicine professor is leading studies showing a World War II chemical weapon antidote to be effective in combating a new enemy: Parkinson’s disease.
Possible New Treatment for Spinal Cord Injuries Identified in Research Led by PVM Professor
Friday, June 15th, 2018 - Research led by a Purdue Veterinary Medicine scholar shows that an experimental drug has promise as a potential therapy for spinal cord injuries in animal studies. The compound, 4-aminopyridine-3-methanol, works in a similar way as a drug previously developed at Purdue, 4-aminopyridine (4-AP), which has been approved by the U.S. Food and Drug Administration to treat multiple sclerosis.
PVM Scholar Featured in Purdue Today Series on Inventors and Innovators
Friday, February 2nd, 2018 - Dr. Riyi Shi, professor of neuroscience and biomedical engineering in Purdue Veterinary Medicine's Department of Basic Medical Sciences and the Weldon School of Biomedical Engineering, was in the spotlight Friday, January 26, as part of a series in the Purdue Today e-newsletter on inventors and innovators.
Faculty Spotlight: Dr. Melissa Lewis
Friday, January 19th, 2018 - Dr. Lewis was appointed as an assistant professor of neurology in September, joining two other neurologists as part of the growing neurology and neurosurgery service in the Purdue University Veterinary Teaching Hospital